Find a Clinical Trial
Filter
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
LYS228 Pharmacokinetics for Complicated UTI
Urinary tract infections
All genders
18-85
Recruiting now
Department of Urology
Discovery
Glaucoma
All genders
No minimum age
Recruiting now
Department of Ophthalmology
ROACTIVE-HF II
Heart failure
All genders
18+
Recruiting now
Division of Cardiology
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
Home and Bedside Visual Fields
Vision health
All genders
15-80
Recruiting now
Department of Ophthalmology
VAPOR 2
Prostate cancer
All genders
50-89
Recruiting now
Department of Urology
ETS3
Vision impairment
All genders
3-9
Recruiting now
Department of Ophthalmology
Infant Vision Health and Prenatal Drug Exposure
Vision health
All genders
0-5
Recruiting now
Department of Obstetrics + Gynecology